A231 P12 PPT
-
Upload
wenny-alexander-elfy -
Category
Documents
-
view
226 -
download
0
Transcript of A231 P12 PPT
-
8/6/2019 A231 P12 PPT
1/31
P12P12TheThe
LongLongWaitWait
Team 2Team 2 Abid, Alia, Zoei, Wenny, NithiyaAbid, Alia, Zoei, Wenny, Nithiya
-
8/6/2019 A231 P12 PPT
2/31
ObjectivesObjectives
Kidney Problem Causes and Complication (Nithiya) What is organ transplantation?
Laboratory test to determine suitable level of organ transplantation (Abid)
Criteria for considering a suitable donor or recipient
Organs/ tissues that can be transplanted (Zoei)
Four Main Category of Transplant Graft V Host Reaction (wenny)
Post transplantation medication (Alia)
- Pros and Cons of these drugs
- Types of immunosuppressive drugs
What is HLA? (wenny)
Different classes of HLA
PROBLEM STATEMENT (Alia)
-
8/6/2019 A231 P12 PPT
3/31
What is organ transplantation?
Is the moving of an organ from one body to
another
Organs that can be transplanted are the heart,kidneys, liver, lungs, pancreas, intestine, and
thymus
Organ donors alive or dead
Transplant region
-
8/6/2019 A231 P12 PPT
4/31
Kidney problemsKidney problems
Kidney slows down or stops working
Kidney failure and several complications
Common types of kidney dieases
Chronic kidney failure Acute kidney failure
ESRD
-
8/6/2019 A231 P12 PPT
5/31
TreatmentTreatment
Dialysis - is a process for removing waste and
excess water from the blood
Not a one time treatment Kidney transplantation
-
8/6/2019 A231 P12 PPT
6/31
Lab test to determine suitable level of organ
transplantation
First test: Blood Type Testing
Second test: Tissue Typing
It is to test out whether the HLA of the donor is compatible with the recipient.
The WBC is accounted for during the tissue typing test.
Third test: Crossmatching Testing of the blood of the recipient to see whether it have a reaction to the donors organ.
If the test is positive, the organ is incompatible. If it is negative, the organ is compatible
Fourth test: Serology:
Blood test conducted for potentially transmitted diseases (HIV, Hepatits)
Recipient's Blood Donors Blood
A A or O
B B or O
O O
AB A, B, AB or O
-
8/6/2019 A231 P12 PPT
7/31
Criteria for considering a suitable donor or
recipient
Same blood type
Compatible HLA
Compatible antibodies
Functional organs
-
8/6/2019 A231 P12 PPT
8/31
Organs / Tissues that can be
Transplanted Organ Transplantation The moving of an organ from one body to
another or from a donor site on the patient's own body
Organs that can be transplanted Heart, Kidneys, Liver, Lungs,
Pancreas, Intestine, and Thymus
Tissues that can be transplanted Bones, Tendons, Cornea, Skin,
Heart Valves, and Veins
Organ donors Living orBrain-dead
Most tissues, except the corneas, can be preserved and stored for
up to five years
-
8/6/2019 A231 P12 PPT
9/31
Four main Types of
Transplantation Autograft- Self transplant- No immune issues from this.
Allograft- Most common type and is transplant of non-identical people
- Immunosuppressants need to be taken to prevent the body from
rejecting this type of transplant
Isograft
- From genetically identical people- Anatomically like allografts, but no immune response
Xenograft
- Transplant from another species
- There will be immune issues and person needs
-
8/6/2019 A231 P12 PPT
10/31
Post Transplantation MedicationPost Transplantation Medication
Immunosuppressive drugs or immunosuppressive agents are drugs thatinhibit or prevent activity of the immune system.
They are used in immunosuppressive therapy to:
Prevent the rejection of transplanted organs and tissues.
Treat autoimmune diseases or diseases that are most likely of autoimmuneorigin.
Treat some other non-autoimmune inflammatory diseases.
Groups of Immunosuppressive Drugs:
Glucocorticoids Cytostatics
Antibodies
Drugs acting on immunophilins
Other Drugs
-
8/6/2019 A231 P12 PPT
11/31
Disadvantages of these medications
It is able to gain infection easily and the spread of malignantcells.
There are also side effects:
- Hypertension- Dyslipidemia
- Hyperglycemia
- Peptic ulcers
- Liver and kidney injury
It also interacts with other medicines and affect theirmetabolism and actions.
-
8/6/2019 A231 P12 PPT
12/31
HLA
Proteins present on the surface of all cells onthe human body.
Resides on chromosome number 6
Recognize foreign cells.
MHC Class I HLA-A, HLA-B, HLA-C
MHC Class II - HLA-DP, HLA-DQ, HLA-DR antigens
-
8/6/2019 A231 P12 PPT
13/31
MHC Class I
Present peptides from inside the cell.
Peptides are produced from digested proteinsthat are broken down in the proteasomes.
MHC Class II
Present antigens from outside of the cell to T-
lymphocytes. Stimulate T-helper cells stimulate antibody-
producing B-cells
-
8/6/2019 A231 P12 PPT
14/31
Graft V Host Reaction
An immunologically competent graft is transplantedinto an immunologically suppressed recipient (host)
Criteria: An immunocompetent graft is administered, with
viable and functional immune cells.
The recipient is immunologically disparate -
histoincompatible. The recipient is immunocompromised and therefore
cannot destroy or inactivate the transplanted cells.
-
8/6/2019 A231 P12 PPT
15/31
Problem
Statement
The every cadavers mentioned in the problem statement should refer to allograft.
Allograft are transplants that are performed between 2 genetically non-identical
members of the same species. Most human tissues/organ transplant are allograft.
Due to the genetic difference between the donor & recipient, the recipients
immune system will detect the organ as foreign object and will try to destroy it
which leads to transplant rejection.
Transplant rejection occurs when a transplanted organ or tissue is not accepted by
the body of the transplant recipient.
When possible, transplant rejection can be reduced through serotyping to
determine the most appropriate donor-recipient match and through the use of
immunosuppressant drugs.
Mr. Teos doctor told him that not every cadaver wasMr. Teos doctor told him that not every cadaver was
suitable for him and transplantation of a nonsuitable for him and transplantation of a non--
compatible kidney will put him in grave danger.compatible kidney will put him in grave danger.
-
8/6/2019 A231 P12 PPT
16/31
Resources
http://en.wikipedia.org/wiki/Transplant_rejection http://en.wikipedia.org/wiki/Human_leukocyte_antigen
-
8/6/2019 A231 P12 PPT
17/31
-
8/6/2019 A231 P12 PPT
18/31
Major Histocompatibility Complex
(MHC)
-
8/6/2019 A231 P12 PPT
19/31
Major Histocompatibility Complex (MHC)
* The MHC is a closely linked complex of genes that govern production ofthe major histocompatibility
* In humans, MHC resides on the short arm of chromosome 6
* Three genes (HLA-A, HLA-B, HLA-C) code for
the class I MHC proteins
* Several HLA-D loci determine the class II MHC proteins i.e. DP, DQ and
DR
* HLA genes are very diverse (polymorphic)
i.e. there are many alleles of the class I and II genes
-
8/6/2019 A231 P12 PPT
20/31
Major Histocompatibility Complex (MHC)
* Between the class I and class II gene loci, there is a third locus (Class
III)
* This locus contains genes encoding tumor necrosis factor,
lymphotoxin and two complement components (C2 and C4)
* Class III antigens do not participate in MHC restriction or graft
rejection
-
8/6/2019 A231 P12 PPT
21/31
MHC Class I Antigens
* Class I MHC antigens are : HLA-A, HLA-B and HLA-C
* These antigens are glycoproteins found on surfaces of all
nucleotide human cells and on platelets
* HLA-A contains 24 different antigenic specificities,
HLA-B contains 52 and HLA-C contains 11
* Class I MHC antigens are involved ofMHC restriction of cell
mediated cytotoxicity
-
8/6/2019 A231 P12 PPT
22/31
MHC Restriction
* Endogenously processed cytosolic peptides in virus infected cells
or tumor cells are transported to the surface of the cells
* They bind to MHC I molecules to be recognized by cytotoxic T-cellswhich then kill these cells
* In other words;
T-cells are only activated when they recognize both antigen andclass I MHC molecules in association
-
8/6/2019 A231 P12 PPT
23/31
MHC Class II Antigens
Class II antigens are: HLA-DP, HLA-DQ, HLA-DR antigens
These antigens are glycoproteins found on the surface of
macrophages, B-cells, Dentritic cells, langerhans cells of skinand activated T cells
HLA-DP contain 6 different antigenic specificities, HLA-DQ
contains 9 and HL
A-DR contains 20
-
8/6/2019 A231 P12 PPT
24/31
MHC Class II Antigens
* Helper T-cells recognize antigens on antigen-presenting cells
only when the antigens are presented on the surface of
cells in association with class II MHC
* Class II antigens react with the CD4 molecule on the helper
T-cells which secrete cytokines
-
8/6/2019 A231 P12 PPT
25/31
Class I MHC and Class II MHC
MHC Class IMHC Class I MHC Class IIMHC Class II
NomenclatureNomenclature HLAHLA--A, HLAA, HLA--B, HLAB, HLA--CC HLAHLA--DP, HLADP, HLA--DQ,DQ,HLAHLA--DRDR
Found onFound on
All nucleated somaticAll nucleated somatic
cellscells
Macrophages, BMacrophages, B--cells,cells,
Dentritic cells,Dentritic cells,langerhans cells of skinlangerhans cells of skin
and activated T cellsand activated T cells
Recognized byRecognized by CD8 TC cellsCD8 TC cells CD4 TH cellsCD4 TH cells
FunctionsFunctions Presentation of Ag toPresentation of Ag toTCTC cells leading tocells leading to
elimination of tumor orelimination of tumor orinfected host cellinfected host cell
Presentation of Ag toPresentation of Ag toTHTH cells whichcells which secretesecrete
cytokinescytokines
-
8/6/2019 A231 P12 PPT
26/31
Transplantation
andGraft Rejection
-
8/6/2019 A231 P12 PPT
27/31
Types of grafts
1) Autografts :
The transfer of an individuals own tissues
from place to place
e.g. Skin grafts (regularly accepted)
2) Isografts :
Transfer oftissues between genetically
identical persons
e.g. Identical twins ( accepted permanently)
-
8/6/2019 A231 P12 PPT
28/31
Types of grafts
3) Allografts (homograft):
- Transfer of a graft between genetically different
members of same species
e.g from one human to another- Rejection occur if donor and recipient are not matched
4) Xenograft (heterograft):
- Transfer of tissues between different species
- Always rejected
-
8/6/2019 A231 P12 PPT
29/31
Mechanism Of Graft Rejection
1) Both TH and TC are activated- TC cells destroy graft cells by direct contact
TH cells secrete cytokines that attract and activate macrophages,NK cells and polymorphs leading to cellular infiltration anddestruction of graft (Type IV)
- B cells recognize foreign antigens on the graft and produceantibodies which bind to graft cells and
. Activate complement causing cell lysis
. Enhance phagocytosis, i.e. opsonization (Type II)
. Lead to ADCC by macrophages, NK,PML
- Immune complex deposition on the vessel walls induce plateletsaggregation and microthrombi leading to ischemia and necrosis
of graft (Type II)
-
8/6/2019 A231 P12 PPT
30/31
Types Of Graft Rejection
!) Hyperacute rejection:
- It occurs hours after transplantation
- In individual with preformed antibodies either due to - blood groupsincompatibility or previous sensitization
by blood transfusion, previous transplantation
2) Acute Rejection:
- It occurs 10 to 30 days after transplantation
- It is mainly T-cell mediated
3) Chronic or late rejection:
- It occurs over a period ofmonths or years
- It may be cell mediated, antibody mediated or both
-
8/6/2019 A231 P12 PPT
31/31
Graft Versus Host (GVH) Reaction
* An immunologically competent graft is transplanted into an
immunologically suppressed recipient (host)
* The grafted cells survive and react against the host cells
i.e instead of reaction of host against the graft,
the reverse occurs
* GVH reaction is characterized by fever, pancytopenia, weight loss, rash ,
diarrhea, hepatsplenomegaly and death